← Back to Search

Informational Support for Prostate Cancer (MiCaP Trial)

N/A

Recruiting

Led By Folakemi T Odedina, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 1 hour after video intervention

Awards & highlights

MiCaP Trial Summary

This trial is researching a way to provide Black men with info about prostate cancer to help them make informed decisions. #prostatecancer

Who is the study for?

This trial is for Black men aged 35-70 with prostate cancer. Participants must have internet and Zoom for online data collection or live in specific areas near the Mayo Clinic Cancer Center if participating in person.Check my eligibility

What is being tested?

The study tests the effectiveness of the Minority Prostate Cancer (MiCaP) Research Digest as a way to inform Black men about prostate cancer research, aiming to aid them in making educated healthcare decisions.See study design

What are the potential side effects?

Since this trial involves survey administration and media intervention, there are no direct medical side effects. However, participants may experience discomfort discussing personal health issues.

MiCaP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 1 hour after video intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 1 hour after video intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 hour after video intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in perception in participation with clinical trials about prostate cancer

Change in perception of access to medical services and general health

Change in perception of familiarity with a research study protocol

+1 more

MiCaP Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MiCaP Research Digest Video GroupExperimental Treatment2 Interventions

Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial.

Group II: Alternate Video GroupActive Control2 Interventions

Participants watch an alternative video on study. Participants complete a survey throughout the trial.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,216 Previous Clinical Trials

3,767,068 Total Patients Enrolled

33 Trials studying Prostate Cancer

7,968 Patients Enrolled for Prostate Cancer

Folakemi T Odedina, PhDPrincipal InvestigatorMayo Clinic

Folakemi T. Odedina, Ph.D.Principal InvestigatorMayo Clinic

Media Library

MiCaP Research Digest Video Group Clinical Trial Eligibility Overview. Trial Name: NCT05895279 — N/A

Prostate Cancer Research Study Groups: MiCaP Research Digest Video Group, Alternate Video Group

Prostate Cancer Clinical Trial 2023: MiCaP Research Digest Video Group Highlights & Side Effects. Trial Name: NCT05895279 — N/A

MiCaP Research Digest Video Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05895279 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research accept participants aged thirty or older?

"This trial is primarily looking for participants between the ages of 35 and 70. Separately, there are 67 trials targeting minors under 18 years old and 1,320 studies recruiting patients who have surpassed 65 years of age."

Answered by AI

What are the criteria for eligibility in this medical experiment?

"The criteria for eligibility in this medical trial is prostate cancer and an age range of 35-70 years. 420 participants are currently being accepted to the study."

Answered by AI

How many volunteers are involved with this research initiative?

"Affirmative. The website clinicaltrials.gov states that enrollment for this investigation is ongoing, with the initial posting taking place on August 2nd 2002 and the most recent update being May 31st 2023. This experiment requires 420 individuals from one site to participate in it."

Answered by AI

Are there any opportunities still available for participants in this investigation?

"By consulting clinicaltrials.gov, one can determine that this study is actively seeking participants. Its existence was first noted on August 2nd 2002 and the most recent update occurred at May 31st 2023."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessment of Research Digest Impact for Minority With Prostate Cancer, MiCAP Phase III Study

2002. "Assessment of Research Digest Impact for Minority With Prostate Cancer, MiCAP Phase III Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05895279.